Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin Add-on to Empagliflozin and Metformin in Type 2 Diabetes Mellitus
2014-004895-48Phase 4Completed
- Sponsor
- Profil
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Change in glucagon release during Liquid Meal Test. Started Mar 2015; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-004895-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004895-48.